Axsome Therapeutics (AXSM) Other Non Operating Income (2015 - 2025)
Axsome Therapeutics' (AXSM) quarterly Other Non Operating Income came in at -$10.4 million in Q2 2025, down 732.79% quarter-over-quarter from -$1.2 million in Q3 2020.
Axsome Therapeutics (AXSM) Other Non Operating Income (2015 - 2025) Analysis & Trends
Axsome Therapeutics has disclosed Other Non Operating Income across 3 years of filings, most recently posting -$10.4 million for Q2 2025.
- Other Non Operating Income for Q2 2025 came in at -$10.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$10.4 million (changed N/A YoY), and the FY2025 annual result was -$10.4 million, changed N/A from the prior year.
- Other Non Operating Income came in at -$10.4 million for Q2 2025 at Axsome Therapeutics, down from -$1.2 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of -$10.4 million in Q2 2025 to a low of -$10.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Axsome Therapeutics | 12.84 Bn | 12.54 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -10.39 Mn |
| Sep 30, 2020 | -1.25 Mn |
| Dec 31, 2015 | -2.72 Mn |
| Sep 30, 2015 | 204,000.00 |
| Jun 30, 2015 | 149,900.00 |
| Mar 31, 2015 | -79,100.00 |